AMANDA BOROFF: Open Payments
NPI 1972139160 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,363 in 112 payments from 20 companies in 2025. Trend: 2023 $1,843 · 2024 $1,824 · 2025 $2,363
Food & beverage: $2,363
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $289 |
| Otsuka America Pharmaceutical, Inc. | 12 | $277 |
| Janssen Pharmaceuticals, Inc | 7 | $238 |
| Alkermes, Inc. | 9 | $211 |
| ABBVIE INC. | 15 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $190 |
| Lundbeck LLC | 7 | $180 |
| Collegium Pharmaceutical, Inc. | 6 | $122 |
| Tris Pharma Inc | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 3 | $91 |
Products named: REXULTI, INGREZZA, ARISTADA, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, Jornay PM, COBENFY.
Industry payments across FL — which companies pay providers there.
